Cardiotoxic chemotherapy drugs

▫ using medications that prolong QT interval or cardiotoxic chemotherapy. cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier

Choose chemotherapy doses with less risk of cardiotoxicity, remembering that the accumulative dose and the schedule of chemotherapy are important factors for cardiotoxicity. Prepare chemotherapy with a lower potential cardiotoxicity effect, for instance in anthracyclines with continuous infusions or altered delivery systems (i.e,liposomal

Cardiotoxicity is when the heart muscle is injured. Chemotherapy drugs known as Anthracyclines can be cardiotoxic.

Cardiotoxicity refers to heart damage caused by certain chemotherapy drugs, heavy metals, and other toxins.

by Z Tlegenova 2024 Cited by 5As known, the clinical efficacy of chemotherapy is limited by the cardiotoxicity of drugs used. The study aimed to clarify cardiotoxic complications of

While antimicrotubular agents such as the taxanes cause cardiotoxicities that include heart block, hypertension, arrythmias, and CHF, recent study of taxane cardiotoxicity has explored if they exacerbate toxicity of other chemotherapy drugs such as anthracyclines or trastuzumab [2,30].

used a stem cell approach to evaluate the cardiotoxicity of a class of chemotherapy drugs. Future research could establish even more

38 Anthracycline cardiotoxicity may present with early or late effects. Cancer chemotherapy handbook. Drugs in Pregnancy and Lactation. 5th ed

Unfortunately, anthracyclines are considered the principal culprit drugs behind chemotherapy-induced cardiotoxicity (1 5). The pathognomonic manifestation of anthracycline-induced cardiotoxicity is a hypokinetic cardiomyopathy progressively leading to heart failure, first described in 2024 ( 6 ).